Annovis Bio Inc (ANVS)

Jun 05, 2026

Annovis Bio Price, ANVS Price, Live Charts, and Marketcap - Coinbase

Jun 05, 2026

Jun 03, 2026

Annovis Regains NYSE Compliance Ahead of Listing Deadline - MyChesCo

Jun 03, 2026

May 29, 2026

Top Annovis Bio (ANVS) Competitors 2026 - MarketBeat

May 29, 2026

May 28, 2026

Maxim Group Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $8 - Moomoo

May 28, 2026

May 26, 2026

Annovis Bio (ANVS) Faces Selling Pressure: Key Levels in Focus After 7.6% DeclineVolume Rate Change - thelegaladvocate.com

May 26, 2026

May 26, 2026

Annovis Bio regains NYSE listing compliance - MSN

May 26, 2026

May 26, 2026

Annovis Bio regains NYSE listing compliance By Investing.com - Investing.com Nigeria

May 26, 2026

May 26, 2026

Annovis Bio Regains NYSE Listing Compliance - The Manila Times

May 26, 2026

May 23, 2026

Annovis launches proposed public stock and warrant offering - MSN

May 23, 2026

May 22, 2026

Annovis Bio Analyst Ratings and Price Targets | NYSE:ANVS - Benzinga

May 22, 2026

May 22, 2026

Annovis Bio director Michael Hoffman buys $142,778 in shares By Investing.com - Investing.com Australia

May 22, 2026

May 21, 2026

Annovis Bio director Michael Hoffman buys $142,778 in shares - Investing.com UK

May 21, 2026

May 21, 2026

3 Parkinson's Biotech Stocks Analysts Think Are Wildly Mispriced - Moomoo

May 21, 2026

May 21, 2026

Annovis Bio (ANVS) Rebounds 5.39%, Tests Key Resistance After Broader Market Upward MomentumCorrective Wave - thelegaladvocate.com

May 21, 2026

May 21, 2026

Director Michael Hoffman adds 76,344 Annovis Bio (ANVS) shares in open-market buys - Stock Titan

May 21, 2026

May 20, 2026

Annovis Bio prices $15 million public offering at $1.90 - Investing.com UK

May 20, 2026

May 20, 2026

Annovis Bio Announces Dilutive Equity Offering for Trials - TipRanks

May 20, 2026

May 20, 2026

Annovis Bio Launches ~$15 Million Stock-and-Warrant Offering Underwritten by Canaccord Genuity - TradingView

May 20, 2026

May 20, 2026

Annovis Bio (NYSE: ANVS) prices $15M common stock and warrant offering - Stock Titan

May 20, 2026

May 20, 2026

Annovis Bio (NYSE: ANVS) raises $13.8M via 7.895M-share offering and warrants - Stock Titan

May 20, 2026

May 20, 2026

Annovis Bio Prices $15 Million Public Offering to Fund Neurodegenerative Disease Trials - MEXC

May 20, 2026

May 20, 2026

Annovis Bio slips after pricing $15M equity offering - MSN

May 20, 2026

May 20, 2026

Annovis announces pricing of $15.0 million public offering of common stock and accompanying warrants - marketscreener.com

May 20, 2026

May 20, 2026

Annovis Bio prices $15 million public offering at $1.90 By Investing.com - Investing.com South Africa

May 20, 2026

May 20, 2026

Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants - The Manila Times

May 20, 2026

May 20, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

May 20, 2026

May 20, 2026

Press Release: Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants - Moomoo

May 20, 2026

May 20, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 20, 2026

May 19, 2026

Annovis Bio Launches Proposed Stock, Warrant Offering; Shares Fall - Moomoo

May 19, 2026

May 19, 2026

Annovis Bio stock tumbles on public offering announcement By Investing.com - Investing.com India

May 19, 2026

May 19, 2026

Annovis Bio announces public offering of stock and warrants By Investing.com - Investing.com South Africa

May 19, 2026

May 19, 2026

Annovis Bio (ANVS) registers equity units with detachable warrants in shelf supplement - Stock Titan

May 19, 2026

May 19, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

May 19, 2026

May 19, 2026

Annovis Bio stock tumbles on public offering announcement - Investing.com

May 19, 2026